Skip Navigation


Carcinogenesis Advance Access originally published online on March 2, 2006
Carcinogenesis 2006 27(8):1670-1675; doi:10.1093/carcin/bgi376
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
27/8/1670    most recent
bgi376v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Miller, K. L.
Right arrow Articles by Nelson, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, K. L.
Right arrow Articles by Nelson, H. H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

XPA, haplotypes, and risk of basal and squamous cell carcinoma

Katie L. Miller1,2, Margaret R. Karagas5, Peter Kraft1,6, David J. Hunter1,6, Paul J. Catalano3,7, Steven H. Byler4 and Heather H. Nelson2,*

1 Department of Epidemiology, Harvard School of Public Health Boston, MA, USA
2 Department of Environmental Health, Harvard School of Public Health Boston, MA, USA
3 Department of Biostatistics, Harvard School of Public Health Boston, MA, USA
4 Department of Genetics and Complex Diseases, Harvard School of Public Health Boston, MA, USA
5 Section of Biostatistics and Epidemiology, Department of Community and Family Medicine and Norris Cotton Cancer Center, Dartmouth Medical School Lebanon, NH, USA
6 Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School Boston, MA, USA
7 Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute Boston, MA, USA

*To whom correspondence should be addressed. Tel: +1 617 432 0037; Fax: +1 617 432 0107; Email: hnelson{at}hsph.harvard.edu

Nucleotide excision repair (NER) is instrumental in removing DNA lesions caused by ultraviolet (UV) radiation, the dominant risk factor for keratinocyte carcinoma, including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). We evaluated whether BCC or SCC risk was influenced by the A23G single nucleotide polymorphism (SNP) in Xeroderma pigmentosum group A (XPA), which codes for an essential protein in NER. We also investigated whether haplotypes of XPA, determined by seven haplotype-tagging SNPs, better define susceptibility to keratinocyte carcinoma. Incident cases of BCC and SCC from New Hampshire were identified through dermatologists and pathology laboratories. Population-based controls were frequency-matched to cases by gender and age. Cases of BCC (886) and of SCC (682) were compared with controls (796). Models controlled for age, gender, pigmentation factors and severe sunburns and were restricted to Caucasians. Using GG as the reference, the A allele was less frequent among cases of BCC (ORAG = 0.82, 95% CI (0.66, 1.01); ORAA= 0.74, 95% CI (0.53, 1.03); trend test P = 0.03) and SCC (ORAG = 0.85, 95% CI (0.67, 1.07); ORAA = 0.74, 95% CI (0.52, 1.05); trend test P = 0.05) than controls. Risk from ≥3 severe sunburns was elevated for those with the GG genotype only, and this interaction was nearly significant for BCC (P = 0.07). XPA genotype also modified a relationship between SCC and the amount of pigmentation (P = 0.02). Using a haplotype analysis identifying seven common XPA haplotypes indicated that the A23G polymorphism alone captured the differences in susceptibility to keratinocyte carcinoma. The common G allele of the A23G polymorphism was associated with an increased risk of BCC and SCC and this polymorphism appeared to be the determining polymorphism in XPA that alters cancer susceptibility.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
Y. Zhu, M. Lai, H. Yang, J. Lin, M. Huang, H.B. Grossman, C. P. Dinney, and X. Wu
Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer
Carcinogenesis, March 1, 2007; 28(3): 698 - 703.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.